| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/31/2023 | Arcutis Biotherapeutics, Inc. | ARQT | Grant | Stock Option (right to buy) | 12.2k | $7.51 | $91.8k | | 05/31/2023 |
| 05/31/2023 | Arcutis Biotherapeutics, Inc. | ARQT | Grant | Common Stock | 4.4k | $0.00 | $0 | | 05/31/2023 |
| 06/16/2022 | Tarsus Pharmaceuticals, Inc. | | Grant | Restricted Stock Units | 2k | $0.00 | $0 | | 06/16/2022 |
| 06/16/2022 | Tarsus Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 7k | $12.89 | $90.2k | | 06/16/2022 |
| 06/01/2022 | Arcutis Biotherapeutics, Inc. | ARQT | Grant | Common Stock | 4.3k | $0.00 | $0 | | 06/01/2022 |
| 06/01/2022 | Arcutis Biotherapeutics, Inc. | ARQT | Grant | Stock Option (Right to Buy) | 11.8k | $20.29 | $239.3k | | 06/01/2022 |
| 06/25/2021 | Arcutis Biotherapeutics, Inc. | ARQT | Sale | Common Stock | 6.8k | $27.50 | $185.8k | | 06/24/2021 |
| 06/24/2021 | Arcutis Biotherapeutics, Inc. | ARQT | Sale | Common Stock | 729 | $27.50 | $20k | | 06/24/2021 |
| 06/21/2021 | Arcutis Biotherapeutics, Inc. | ARQT | Sale | Common Stock | 2.5k | $27.50 | $69.2k | | 06/21/2021 |
| 06/15/2021 | Tarsus Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 10k | $35.26 | $352.6k | | 06/15/2021 |
| 06/09/2021 | Arcutis Biotherapeutics, Inc. | ARQT | Grant | Stock Option (Right to Buy) | 13.4k | $27.77 | $371.9k | | 06/09/2021 |
| 06/01/2021 | Arcutis Biotherapeutics, Inc. | ARQT | Sale | Common Stock | 10k | $27.50 | $275k | | 06/01/2021 |
| 04/20/2021 | Arcutis Biotherapeutics, Inc. | ARQT | Sale | Common Stock | 1.3k | $28.53 | $36.5k | | 04/20/2021 |
| 04/20/2021 | Arcutis Biotherapeutics, Inc. | ARQT | Sale | Common Stock | 8.7k | $27.99 | $244.1k | | 04/20/2021 |
| 04/20/2021 | Arcutis Biotherapeutics, Inc. | ARQT | Sale | Common Stock | 8.7k | $27.99 | $244.1k | | 04/20/2021 |
| 04/20/2021 | Arcutis Biotherapeutics, Inc. | ARQT | Sale | Common Stock | 1.3k | $28.53 | $36.5k | | 04/20/2021 |
| 03/22/2021 | Arcutis Biotherapeutics, Inc. | ARQT | Sale | Common Stock | 5k | $30.77 | $154.1k | | 03/22/2021 |
| 03/22/2021 | Arcutis Biotherapeutics, Inc. | ARQT | Sale | Common Stock | 5k | $31.43 | $156.9k | | 03/22/2021 |
| 02/22/2021 | Arcutis Biotherapeutics, Inc. | ARQT | Sale | Common Stock | 7.2k | $35.34 | $254.9k | | 02/22/2021 |
| 02/22/2021 | Arcutis Biotherapeutics, Inc. | ARQT | Sale | Common Stock | 2.8k | $35.97 | $100.3k | | 02/22/2021 |
| 02/01/2021 | Arcutis Biotherapeutics, Inc. | ARQT | Sale | Common Stock | 9.9k | $33.25 | $330.8k | | 01/29/2021 |
| 01/29/2021 | Arcutis Biotherapeutics, Inc. | ARQT | Sale | Common Stock | 51 | $27.50 | $1.4k | | 01/29/2021 |
| 02/27/2020 | Arcutis Biotherapeutics, Inc. | ARQT | Grant | Stock Option (Right to Buy) | 24k | $27.61 | $662.6k | | 02/27/2020 |
| 02/04/2020 | Arcutis Biotherapeutics, Inc. | ARQT | Conversion | Common Stock | 37.5k | $0.00 | $0 | | 02/04/2020 |
| 02/04/2020 | Arcutis Biotherapeutics, Inc. | ARQT | Conversion | Common Stock | 50k | $0.00 | $0 | By Trust | 02/04/2020 |
| 02/04/2020 | Arcutis Biotherapeutics, Inc. | ARQT | Conversion | Series A Preferred Stock | 37.5k | $0.00 | $0 | | 02/04/2020 |
| 02/04/2020 | Arcutis Biotherapeutics, Inc. | ARQT | Conversion | Series A Preferred Stock | 50k | $0.00 | $0 | By Trust | 02/04/2020 |
| 01/02/2020 | Teligent, Inc. | TLGT | Grant | Stock Option | 20k | $0.42 | $8.3k | | 01/02/2020 |
| 07/01/2019 | Teligent, Inc. | TLGT | Grant | | 16.3k | $0.65 | $10.6k | | 07/01/2019 |
| 06/03/2019 | Teligent, Inc. | TLGT | Purchase | Common Stock | 10k | $0.70 | $7k | | 06/03/2019 |
| 05/13/2019 | Teligent, Inc. | TLGT | Grant | | 13.1k | $0.86 | $11.2k | | 05/13/2019 |
| 05/13/2019 | Teligent, Inc. | TLGT | Grant | | 12.4k | $0.86 | $10.6k | | 05/13/2019 |
| 01/02/2019 | Teligent, Inc. | TLGT | Grant | Stock Option | 20k | $1.32 | $26.4k | | 01/02/2019 |
| 11/27/2018 | Corium International, Inc. | CORI | Disposition | Director Stock Option (Right to Buy) | 15k | $11.59 | $173.8k | | 11/27/2018 |
| 11/27/2018 | Corium International, Inc. | CORI | Disposition | Director Stock Option (Right to Buy) | 34.2k | $2.22 | $76k | | 11/27/2018 |
|